WAP
TLMDW

Wealthcare Advisory Partners’s SOC Telemed, Inc. Warrants TLMDW Stock Holding History

Wealthcare Advisory Partners’s Portfolio TLMDW Stock Details TLMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$5K – 2065
2021
Q1 		$5K Buy
+5,000
New +$6.37K ﹤0.01% 1675

Other funds holding TLMDW

ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Wealthcare Advisory Partners's TLMDW Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of SOC Telemed, Inc. Warrants (TLMDW) in Q2 2021, closing a stake of 5,000 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in TLMDW in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 9 funds tracked by Wall St. Rank hold TLMDW as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining SOC Telemed, Inc. Warrants position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 5,000 SOC Telemed, Inc. Warrants shares in Q2 2021, an estimated $5K.
  • Wealthcare Advisory Partners first reported a position in SOC Telemed, Inc. Warrants in Q1 2021 and held it in 1 quarter.
  • Wealthcare Advisory Partners's SOC Telemed, Inc. Warrants position peaked at $5K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held SOC Telemed, Inc. Warrants as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.